Effect of Propranolol on Responses to Drug-Related Imagery Scripts
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine Dependence
Intervention: propranolol (Drug); placebo (Drug)
Phase: Phase 1
Status: Recruiting
Sponsored by: National Institute on Drug Abuse (NIDA) Overall contact:
Kenzie Preston, Ph.D., Phone: 443-740-2326, Email: kpreston@intra.nida.nih.gov
Summary
This study evaluates the effect of propranolol on drug-related memories.
Clinical Details
Official title: Effect of Propranolol on Responses to Drug-Related Imagery Scripts
Study design: Basic Science, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: drug craving
Secondary outcome: galvanic skin response
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- cocaine use; enrolled in methadone maintenance therapy; age 18-55
Exclusion Criteria:
- allergy or hypersensitivity to propranolol; medical or psychiatric disorder that
would contraindicate propranolol administration; pregnant or breast feeding; taking
medications that would contraindicate propranolol administration
Locations and Contacts
Kenzie Preston, Ph.D., Phone: 443-740-2326, Email: kpreston@intra.nida.nih.gov
NIDA Intramural Research Program, Baltimore, Maryland 21224, United States; Recruiting
Kenzie Preston, Ph, Phone: 443-740-2326, Email: kpreston@intra.nida.nih.gov
Additional Information
Starting date: May 2008
Last updated: May 30, 2008
|
